STAT3 and vitiligo: Based on the findings of the “component-target-disease” network, GO and KEGG analysis, and molecular docking, we hypothesized that the STAT3 and JAK-STAT pathways may be involved in the therapeutic molecular mechanism of FHB in vitiligo.